NIH Pain Consortium: How to build a budget
#10 in the NIH Pain Consortium Grant-Mechanism Webinar Series The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the […]
#10 in the NIH Pain Consortium Grant-Mechanism Webinar Series The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the […]
The INS 15th World Congress, themed Neuromodulation: From Scientific Theory to Revolutionary Therapy, will emphasize the field’s transformative force on disease treatment.
Join the 29th Napa Pain Conference! Since its founding in 1990 by Dr. Eric J. Grigsby, Neurovations Education has set the bar for quality education, breaking research, and networking. Innovation happens here. […]
World Society for Stereotactic and Functional Neurosurgery 2022 | Icheon, Korea
We welcome Penney Cowan to the podium for the 8th lecture honoring the foundational contributions of leaders in pain medicine.
This webinar will offer an overview of the upcoming PURPOSE network. PURPOSE stands for "Positively Uniting Researchers of Pain to Opine, Synthesize, & Engage", and that is exactly its goal: […]
Kauai Pain Conference Designed forAll Providers The Kaua’i Pain Conference is where health care providers, policy makers, administrators and insurers develop interprofessional solutions to the complex challenges of pain management. […]
A significant amount of research has indicated that many, if not all, types of pain are undertreated. Some data indicate that only 25% of patients treated for pain receive adequate […]
The theme this year is a legacy of innovation. We invite you to partner in this theme with us. Join us as we celebrate 30 years of innovation! Earn CME […]
Registration for the 30th Napa Pain Conference is now open!
The comorbidity, co-prescribing, and co-occurrence of disability among persons with chronic pain create greater challenges in managing each condition and reducing impact. Pain cannot be managed in isolation. (Wallace, 2004) […]
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
